Michigan State University Gift, Grant and Contract Report 2026-06-12
TransCode Funds Metastatic Cancer Therapeutics Research
Trusted by teams at
Description
Michigan State University’s Board of Trustees approved acceptance of a $2,100,945 new research award from TransCode Therapeutics Inc to the Department of Radiology Human Medicine. The five-year project will support development of TTX-based therapeutics for metastatic cancer through 2031.
Contract Details
Contract Amount
$2,100,945
Vendor
TRANSCODE THERAPEUTICS INC
Agency
Michigan State University, MI
Contract Type
OTHER
Document Date
June 12, 2026
Contract Term
04/11/2026 – 04/10/2031
Renewal Date
2031-04-10
Renewal Info
New multi‑year sponsored research award; any renewals or extensions would depend on future sponsor actions and are not specified in the report.
More from Michigan State University
Michigan State University Gift, Grant and Contract Report 2026-06-12
Michigan State University Gift, Grant and Contract Report 2026-06-12
Michigan State University Gift, Grant and Contract Report 2026-06-12
Michigan State University Gift, Grant and Contract Report 2026-06-12
Michigan State University Gift, Grant and Contract Report 2026-06-12
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.